🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs
5,427

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Page 112 of 114

  1. risankizumab placebo, Risankizumab, ABBV-066 / Risankizumab, ABBV-066

    AbbVie Deutschland GmbH & Co. KG

    Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  2. rituximab; recombinant human thrombopoietin (rhTPO)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Purpura

    phase 3 small molecule completed

    1 trial

  3. robot-assisted surgery

    Hospital Authority, Hong Kong

    Rectal Cancer

    phase 3 other active

    1 trial

  4. rosiglitazone

    Novo Nordisk A/S

    Diabetes

    phase 3 small molecule terminated

    1 trial

  5. rozerem

    Takeda

    Insomnia

    phase 3 small molecule completed

    1 trial

  6. rt-PA

    Beijing Tiantan Hospital

    Acute Ischemic Stroke

    phase 3 small molecule completed

    1 trial

  7. sIPV-bOPV-bOPV vaccination schedule

    Sinovac Research and Development Co.,

    Poliomyelitis

    phase 3 mab completed

    1 trial

  8. sIPV-sIPV-bOPV vaccination schedule

    Sinovac Research and Development Co.,

    Poliomyelitis

    phase 3 mab completed

    1 trial

  9. same excipients except no hypromellose, PREDNISONE , SAR445761 - belumosudil, PREDNISOLONE

    Sanofi-aventis Healthcare Pty Ltd

    chronic graft versus host disease

    phase 3 small molecule active

    1 trial

  10. sapropterin

    BioMarin Pharmaceutical Australia Pty Ltd

    Behavioral Manifestations of Lesch-Nyhan Disease

    phase 3 small molecule terminated

    1 trial

  11. sapropterin dihydrochloride, 6R-BH4, tetrahydrobiopterin

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonurias

    phase 3 small molecule completed

    1 trial

  12. sarilumab SAR153191 (REGN88)

    Regeneron UK Limited

    Rheumatoid Arthritis

    phase 3 small molecule completed

    6 trials

  13. secukinumab

    Novartis Pharmaceuticals

    Lupus Nephritis

    phase 3 small molecule terminated

    1 trial

  14. selenase (selenium)

    United Therapeutics Europe Ltd

    Osteoporosis

    phase 3 other completed

    1 trial

  15. semaglutide

    Novo Nordisk A/S

    Diabetes

    phase 3 small molecule completed

    4 trials

  16. sepofarsen

    ProQR Therapeutics N.V.

    Leber Congenital Amaurosis 10

    phase 3 small molecule active

    2 trials

  17. serplulimab、bevacizumab

    Changhai Hospital

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  18. setrusumab

    Ultragenyx UK Limited

    Osteogenesis Imperfecta

    phase 3 mab active

    1 trial

  19. shenfu injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Shock

    phase 3 small molecule active

    1 trial

  20. sildenafil

    Pfizer

    Hypertension, Pulmonary

    phase 3 small molecule completed

    1 trial

  21. six courses of zanubrutinib, rituximab and lenalidomide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diffuse Large B-Cell Lymphoma

    phase 3 small molecule active

    1 trial

  22. somapacitan

    Novo Nordisk A/S

    Growth Hormone Disorder

    phase 3 small molecule completed

    1 trial

  23. sotatercept, PL1 - Powder for injection

    Lacuna Pharma Pty Ltd

    Therapeutic confirmatory (phase III)

    phase 3 small molecule active

    1 trial

  24. sotatercept, sotatercept

    Lacuna Pharma Pty Ltd

    Pulmonary Arterial Hypertension (PAH)

    phase 3 small molecule active

    1 trial

  25. sotrovimab

    Vir Biotechnology

    Covid19

    phase 3 mab terminated

    3 trials

  26. soy protein isolate

    Ultragenyx UK Limited

    Hereditary Hemorrhagic Telangiectasia

    phase 3 small molecule completed

    1 trial

  27. sparsentan

    Travere Therapeutics

    Focal Segmental Glomerulosclerosis

    phase 3 small molecule active

    2 trials

  28. sparsentan

    Travere Therapeutics

    Immunoglobulin A Nephropathy

    phase 3 small molecule active

    3 trials

  29. stavudine, efavirenz, lamivudine

    Bristol-Myers Squibb

    HIV Infections

    phase 3 small molecule completed

    1 trial

  30. strengths-based case management

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 3 other completed

    1 trial

  31. sunitinib malate

    Pfizer

    Carcinoma, Hepatocellular

    phase 3 small molecule terminated

    1 trial

  32. supersaturated calcium-phosphate

    Jazz Pharmaceuticals Ireland Limited

    Oral Complaints

    phase 3 other completed

    1 trial

  33. survodutide

    Boehringer Ingelheim

    Obesity

    phase 3 other active

    1 trial

  34. tacrolimus

    Astellas Pharma Inc

    Kidney Transplantation

    phase 3 small molecule completed

    1 trial

  35. tacrolimus capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    phase 3 small molecule terminated

    1 trial

  36. talazoparib plus enzalutamide

    Pfizer

    Prostate Cancer

    phase 3 small molecule active

    1 trial

  37. tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Smith-Magenis Syndrome

    phase 3 small molecule completed

    1 trial

  38. tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Non 24 Hour Sleep Wake Disorder

    phase 3 small molecule active

    4 trials

  39. tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Major Depressive Disorder

    phase 3 small molecule completed

    1 trial

  40. teclistamab, teclistamab, JNJ-79635322, JNJ-79635322

    Janssen-Cilag International N.V.

    Relapsed or Refractory Multiple Myeloma

    phase 3 small molecule active

    1 trial

  41. teduglutide 0.05 mg/kg/d

    Takeda

    Short Bowel Syndrome

    phase 3 small molecule completed

    1 trial

  42. telbivudine or lamivudine

    Novartis Pharmaceuticals

    Chronic Hepatitis B

    phase 3 small molecule completed

    1 trial

  43. telmisartan/amlodipine 40/5 mg fixed combination

    Boehringer Ingelheim

    Hypertension

    phase 3 small molecule completed

    1 trial

  44. the Shouhui Tongbian Capsule

    The First People's Hospital of Lianyungang

    OIC

    phase 3 small molecule active

    1 trial

  45. three consecutive lots of EV71 vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    phase 3 mab completed

    1 trial

  46. ticagrelor

    The First People's Hospital of Lianyungang

    Coronary Artery Disease

    phase 3 small molecule active

    1 trial

  47. tigecycline

    Wyeth is now a wholly owned subsidiary of Pfizer

    Community-Acquired Infections

    phase 3 small molecule completed

    1 trial

  48. tiotropium

    Boehringer Ingelheim

    Pulmonary Disease, Chronic Obstructive

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.